Gemcitabine 1000mg Injection Citafine
Trade Name:– Citafine
Manufacturer: Emcure Pharmaceuticals Ltd
What is the best way to administer a Gemcitabine 1000mg Injection?
Gemcitabine 1000mg Injection is available as a powder that must be combined with fluids and injected intravenously (into a vein) by a doctor or nurse in a medical institution over the course of 30 minutes. Gemcitabine is much of the time given on unambiguous days at regular intervals to treat ovarian or bosom malignant growth.
What is the purpose of gemcitabine?
Descriptions: Gemcitabine injection is used in combination with other drugs (e.g., carboplatin) to treat patients with advanced ovarian cancer who have relapsed after receiving previous cancer treatments for at least 6 months (platinum-based).
What are the negative effects of chemotherapy with Gemcitabine 1000mg Injection?
- For people receiving gemcitabine, the following adverse effects are common (occurring in more than 30% of cases):
- Symptoms of the flu (muscle pain, fever, headache, chills, fatigue)
- It’s a fever (inside 6-12 hours of the principal portion).
- nausea (mild)
- Appetite problems
- A rash on the skin
- Blood counts are low.
When should you have gemcitabine?
Gemcitabine 1000mg Injection is a chemotherapy drug that is used to treat some cancers (including breast, lung, ovarian, and pancreatic). It’s a cancer-fighting medicine that slows or stops cancer cell proliferation.
What is the most extreme measure of time you can take gemcitabine?
Gemcitabine is as often as possible controlled throughout various treatment cycles. This implies that you’ll take the medicine and then take a break to let your body recuperate.A gemcitabine cycle ordinarily endures 3 to 4 weeks (21 to 28 days). Gemcitabine is regularly allowed once per week for half a month, trailed by seven days without treatment.
What is the effectiveness of gemcitabine?
Since 1997, gemcitabine therapy has been the conventional first-line treatment for unresectable locally advanced or metastatic pancreatic cancer patients. The 5-year survival rate for patients with metastatic illness is barely 2%,1 and 1-year survival rates of 17 to 23 percent have been recorded with gemcitabine.
Is Gemcitabine 1000mg Injection a drug that weakens the immune system?
As indicated by this review, gemcitabine produces a huge decrease in lymphocytes. It smothers the humoral insusceptible reaction while saving antigen-explicit cell invulnerability.
Gemcitabine is used to treat a number of malignancies.
One of the most promising new cytotoxic agents is gemcitabine, which is a pyrimidine nucleoside antimetabolite. The medicine has been licensed to treat non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer after showing action in a range of solid tumors.
Assuming that you are searching for another item or brand click on our products.